JW
JW (Cayman) Therapeutics Co. Ltd
JWCTF · OTC
$0.36 +75.62% (+$0.15)
Market Cap ¥564.0M
P/E Ratio -
Div. Yield -
ROE 52.57%
Bulios Fair Price
$0.19
46.5% downside
Current Price
$0.36
Undervalued Fair Value Overvalued
According to Bulios Fair Price, JWCTF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
87 /100
Cheap P/B 1.01x
P/S 2.04x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 38.17%
Rev. growth 23.78%
FCF growth N/A
Profitability
17 /100
Weak Net margin 195.77%
Op. margin 87.48%
FCF margin 28.39%
Quality
3 /100
Poor ROE 52.57%
ROA 54.79%
Asset turnover 0.28x
Debt
56 /100
Moderate Current ratio 1.45x
Int. coverage -21.70x
Debt/Equity 0.47x
Stability
31 /100
Unstable Rev. volatility 42.54%
EPS volatility 8.97%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about JWCTF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Tian Feng
Employees
314
Headquarters
Shanghai
Upcoming events
01 APR
Earnings
Upcoming earnings report